Table of Contents

company-logo

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. It operates through Lifecore, Curation Foods, and Other segments. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, including technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. This segment sells its non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets. The Curation Foods segment engages in processing, marketing, and selling of olive oils and wine vinegars under the O brand; and guacamole and avocado food products under the Yucatan and Cabo Fresh brands, as well as various private labels. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was incorporated in 1986 and is headquartered in Santa Maria, California.

Lifecore Biomedical Dividend Announcement

• Lifecore Biomedical does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Lifecore Biomedical dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Lifecore Biomedical Dividend History

Lifecore Biomedical Dividend Yield

Lifecore Biomedical current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Lifecore Biomedical stock? Use our calculator to estimate your expected dividend yield:

Lifecore Biomedical Financial Ratios

P/E ratio30.87
PEG ratio-0.69
P/B ratio-51.24
ROE17.23%
Payout ratio12.33%
Current ratio1.83
Quick ratio0.80
Cash Ratio0.14

Lifecore Biomedical Dividend FAQ

Does Lifecore Biomedical stock pay dividends?
Lifecore Biomedical does not currently pay dividends to its shareholders.
Has Lifecore Biomedical ever paid a dividend?
No, Lifecore Biomedical has no a history of paying dividends to its shareholders. Lifecore Biomedical is not known for its dividend payments.
Why doesn't Lifecore Biomedical pay dividends?
There are several potential reasons why Lifecore Biomedical would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Lifecore Biomedical ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Lifecore Biomedical has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Lifecore Biomedical a dividend aristocrat?
Lifecore Biomedical is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Lifecore Biomedical a dividend king?
Lifecore Biomedical is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Lifecore Biomedical a dividend stock?
No, Lifecore Biomedical is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Lifecore Biomedical stocks?
To buy Lifecore Biomedical you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Lifecore Biomedical stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.